Dr. Avi Weisfogel holds a degree in psychology and biology from Rutgers University. He also holds a DDS from the College of Dentistry at New York University. Dr. Avi Weisfogel is a sports enthusiast. He is a New York Knicks fan. He also loves playing and watching tennis.
Research medical information is beneficial if made available to the public. The research information is always researched by the most learned and experienced medical practitioners and researchers. Therefore, Oncotarget has come to help researchers and medical practitioners to publish their great work on oncology and other medical-related information. Oncotarget has been publishing one issue per week, but due to demand, importance, and quality of the information, they will be publishing two issues per week.
Oncotarget; a medical journal was established in 2010, and it is peer-reviewed which is accessed openly. It publishes important information which covers many aspects of oncology. With experienced researchers like Mikhail Biagoskionny and Andrel Gudkov as the editors in chief, Oncotarget has published necessary papers and information relating to oncology. They ensure that the information is credible, well researched and helpful in the medical sector. Authors are required to provide a reference for their work in recent papers to appear in the journal and read full article.
Oncotarget has an impact factor of 5.168 which is as a result of their popularity which is attributed to their accurate, insightful and constructive research papers availed in the journal. This helps the authors to have a significant impact on the medical sector with their research. When these papers are availed online, they help describe and explain specific medical issues that affect the society. The research papers can be printed as a result of particular demand. The main aim of Oncotarget is to help enhance peoplelive comfortable lives without diseases and what Oncotarget knows.
Oncotarget’s primary goal is to avail scientific results to many people and very fast. Through insightful reviews, the impact of the research is maximized. Oncotarget eliminates the border between experts and shares distinct discoveries as soon as they happen. Oncotarget has been very transformational in helping researchers publish their work and Oncotarget’s lacrosse camp.
On top of publishing oncology research papers, Oncotarget publishes endocrinology, age-related diseases, immunology, and pathology papers. This has made more research papers available to people, and it has helped many researchers who are not in the oncology field share their discoveries. This means Oncotarget has been very pivotal in research and it will continue to avail more research information. Very soon Oncotarget will start availing neuroscience and stem cell research works and Oncotarget on Facebook.